ISS Recommends a Vote "FOR" All Infusystem Holdings, Inc. Annual Meeting Agenda Items
April 23 2014 - 12:47PM
Marketwired
ISS Recommends a Vote "FOR" All Infusystem Holdings, Inc. Annual
Meeting Agenda Items
MADISON HEIGHTS,
MI--(Marketwired - April 23, 2014) - InfuSystem
Holdings, Inc. (NYSEMKT: INFU), a
leading national provider of infusion pumps and related services
for the U.S. healthcare industry, today announced that
Institutional Shareholder Services (ISS), a leading independent
proxy advisory service, has recommended a "FOR" vote on all
proposals appearing in the Company's Proxy Statement for the 2014
Annual Meeting of Stockholders to be held on May 8, 2014.
Stockholders who have questions in connection with these
proposals, or who need assistance in voting their shares, are asked
to call the Company's Proxy Solicitation firm:
Georgeson Inc.866-482-4931
About InfuSystem Holdings, Inc.InfuSystem Holdings, Inc. is a
leading provider of infusion pumps and related services to
hospitals, oncology practices and other alternate site healthcare
providers. Headquartered in Madison Heights, Michigan, the
Company delivers local, field-based customer support and also
operates Centers of Excellence in Michigan, Kansas, California,
Texas and Ontario, Canada. The Company's stock is traded on
the NYSEMKT under the symbol INFU.
Forward-Looking StatementsCertain statements contained in this
release are forward-looking statements and are based on future
expectations, plans and prospects for InfuSystem Holdings, Inc.'s
("InfuSystem," "INFU," "the Company," "We") business and operations
that involve a number of risks and uncertainties. The
Company's outlook for 2014 and other forward-looking statements in
this release are made as of April 23, 2014, and the Company
disclaims any duty to supplement, update or revise such statements
on a going-forward basis, whether as a result of subsequent
developments, changed expectations or otherwise. In connection with
the "safe harbor" provisions of the Private Securities Litigation
Reform Act of 1995, the Company is identifying certain factors that
could cause actual results to differ, perhaps materially, from
those indicated by these forward-looking statements. Those
factors, risks and uncertainties include, but are not limited to,
potential changes in overall healthcare reimbursement -- including
CMS competitive bidding, sequestration, concentration of customers,
increased focus on early detection of cancer, competitive
treatments, dependency on Medicare Supplier Number, availability of
chemotherapy drugs, global financial conditions, changes and
enforcement of state and federal laws, natural forces, competition,
dependency on suppliers, risks in acquisitions & joint
ventures, US Healthcare Reform, relationships with healthcare
professionals and organizations, technological changes related to
infusion therapy, dependency on websites and intellectual property,
the ability of the Company to successfully integrate acquired
businesses, dependency on key personnel, dependency on banking
relations and covenants, and other risks associated with our common
stock, as well as any other litigation to which the Company may be
subject from time to time; and other risk factors as discussed in
the Company's annual report on Form 10-K for the year ended
December 31, 2013 and in other filings made by the Company from
time to time with the Securities and Exchange Commission.
Additional information about InfuSystem Holdings, Inc.,
including materials relating to its 2014 Annual Meeting of
Stockholders, is available at www.infusystem.com.
CONTACT: Rob SwadoshThe Dilenschneider
Group212-922-0900
InfuSystems (AMEX:INFU)
Historical Stock Chart
From Mar 2024 to Apr 2024
InfuSystems (AMEX:INFU)
Historical Stock Chart
From Apr 2023 to Apr 2024